ClinicalTrials.govcontrolled
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
ClinicalTrials.gov study NCT04466150. IPD Sharing: YES. Countries: 1. Publications: 45.
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8